219 related articles for article (PubMed ID: 2272712)
1. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712
[TBL] [Abstract][Full Text] [Related]
2. Criteria of drug-induced liver disorders. Report of an international consensus meeting.
Bénichou C
J Hepatol; 1990 Sep; 11(2):272-6. PubMed ID: 2254635
[TBL] [Abstract][Full Text] [Related]
3. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia.
Int J Clin Pharmacol Ther Toxicol; 1991 Feb; 29(2):75-81. PubMed ID: 2026468
[TBL] [Abstract][Full Text] [Related]
4. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting.
Benichou C; Solal Celigny P
Nouv Rev Fr Hematol (1978); 1991; 33(3):257-62. PubMed ID: 1956763
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
[TBL] [Abstract][Full Text] [Related]
6. [Criteria of imputation of acute hepatitis to a drug. Results of consensus meetings].
Danan G; Bénichou C; Begaud B; Biour M; Couzigou P; Evreux JC; Lagier G; Berthelot P; Benhamou JP
Gastroenterol Clin Biol; 1987; 11(8-9):581-5. PubMed ID: 3308618
[TBL] [Abstract][Full Text] [Related]
7. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
[TBL] [Abstract][Full Text] [Related]
8. Accuracy and reproducibility of two scales in causality assessment of unexpected hepatotoxicity.
Miljkovic MM; Dobric S; Dragojevic-Simic V
J Clin Pharm Ther; 2012 Apr; 37(2):196-203. PubMed ID: 21718339
[TBL] [Abstract][Full Text] [Related]
9. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
Danan G; Teschke R
Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
[TBL] [Abstract][Full Text] [Related]
10. Case definition and phenotype standardization in drug-induced liver injury.
Aithal GP; Watkins PB; Andrade RJ; Larrey D; Molokhia M; Takikawa H; Hunt CM; Wilke RA; Avigan M; Kaplowitz N; Bjornsson E; Daly AK
Clin Pharmacol Ther; 2011 Jun; 89(6):806-15. PubMed ID: 21544079
[TBL] [Abstract][Full Text] [Related]
11. [Drug-induced renal insufficiency. Results of consensus meetings].
Vigeral P; Baumelou A; Bénichou C; Castot A; Danan G; Kreft-Jais C; Lagier G; Rothschild E; Druet P; Grünfeld JP
Nephrologie; 1989; 10(3):157-61. PubMed ID: 2691914
[TBL] [Abstract][Full Text] [Related]
12. [Definitions and assessment criteria of acute drug-induced hepatitis. Conclusions of an International Consensus Meeting].
Danan G
Gastroenterol Clin Biol; 1991; 15(11):845-8. PubMed ID: 1769475
[No Abstract] [Full Text] [Related]
13. Causality assessment methods in drug induced liver injury: strengths and weaknesses.
García-Cortés M; Stephens C; Lucena MI; Fernández-Castañer A; Andrade RJ
J Hepatol; 2011 Sep; 55(3):683-691. PubMed ID: 21349301
[TBL] [Abstract][Full Text] [Related]
14. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?
Teschke R; Wolff A
Regul Toxicol Pharmacol; 2011 Feb; 59(1):1-7. PubMed ID: 20854865
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacovigilance and herbal hepatotoxicity: critical aspects and solutions].
Teschke R; Schulze J
Dtsch Med Wochenschr; 2013 Feb; 138(6):281-4. PubMed ID: 23361353
[TBL] [Abstract][Full Text] [Related]
16. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
Teschke R
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
[TBL] [Abstract][Full Text] [Related]
17. [Drug-induced hepatic involvement, something to consider!].
Oestreicher MK; Desmeules J; Giostra E; Gross B; Hadengue A; Dayer P
Schweiz Med Wochenschr; 1996 Nov; 126(48):2094-6. PubMed ID: 8992632
[TBL] [Abstract][Full Text] [Related]
18. Causality assessment in pharmacovigilance: The French method and its successive updates.
Miremont-Salamé G; Théophile H; Haramburu F; Bégaud B
Therapie; 2016 Apr; 71(2):179-86. PubMed ID: 27080836
[TBL] [Abstract][Full Text] [Related]
19. [Toxic liver disease due to drugs, herbs and dietary supplements: diagnostic approaches].
Teschke R; Schwarzenböck A; Hennermann KH
Z Gastroenterol; 2007 Feb; 45(2):195-208. PubMed ID: 17304407
[TBL] [Abstract][Full Text] [Related]
20. Updating the French method for the causality assessment of adverse drug reactions.
Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB;
Therapie; 2013; 68(2):69-76. PubMed ID: 23773347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
